Research location

Sagamihara

Kanagawa, Japan

Published trials110
Site observations117
Linked trials published110
Page3 / 3
Advertisement

Research activity in Sagamihara

Kanagawa, Japan

CureCurrent currently publishes aggregate city-level research activity for this location: 110 trials and 117 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Sagamihara

110 linked trials · page 3 of 3
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).NCT00383019 · 2006-11-14 · 1 site observation
COMPLETED
Study Evaluating the Efficacy and Safety of Etanercept and Methotrexate in Japanese Subjects With Rheumatoid ArthritisNCT00445770 · 2006-07-01 · 1 site observation
COMPLETED
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mgNCT00305448 · 2006-03-01 · 1 site observation
COMPLETED
Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast CancerNCT00143390 · 2005-04-01 · 1 site observation
COMPLETED
Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.NCT00225524 · 2004-09-01 · 2 site observations
COMPLETED
Study Evaluating Effexor XR for Major Depression.NCT00225511 · 2004-06-01 · 2 site observations
COMPLETED
Study Evaluating Effexor XR in Elderly Patients With Major Depression.NCT00225485 · 2003-12-01 · 1 site observation
COMPLETED
Iressa Case Control Study in JapanNCT00252759 · 2003-11-01 · 1 site observation
COMPLETED
Iressa 2nd Line Phase III Study in JapanNCT00252707 · 2003-09-01 · 1 site observation
COMPLETED
A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 and 10 mg of E2020NCT00165659 · 2002-11-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.